All Stories

  1. Plakoglobin regulates adipocyte differentiation independently of the Wnt/β-catenin signaling pathway
  2. Identification of RSK substrates using an analog-sensitive kinase approach
  3. The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma
  4. CBFA2T3::GLIS2 Pediatric Acute Megakaryoblastic Leukemia is Sensitive to BCL-XL Inhibition by Navitoclax and DT2216
  5. Synergistic action of actin binding proteins regulate actin network organization and cell shape
  6. Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer
  7. HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
  8. The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma
  9. In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer
  10. Identification of Novel Antigens for Normal Karyotype Triple Mutated Acute Myeloid Leukemia
  11. Identification of Novel Cell Surface Therapeutic Targets for KMT2A-Rearranged Acute Myeloid Leukemia
  12. CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma
  13. Proteomic analysis of the actin cortex in interphase and mitosis
  14. CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells
  15. 1396-P: Critical Cellular Functions That Mediate the Early Stages of Adipogenesis Are Directly Influenced by 14-3-3zeta and Its Interactome
  16. Triglyceride-derived fatty acids reduce autophagy in a model of retinal angiomatous proliferation
  17. In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer
  18. Proteomic analysis of the actin cortex in interphase and mitosis
  19. Plakoglobin regulates adipocyte differentiation independently of the Wnt/β-catenin signalling pathway
  20. Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb
  21. RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit
  22. Transmembrane receptor DCC associates with protein synthesis machinery and regulates translation
  23. Correction: RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation
  24. Sustained ERK1/2 signaling is necessary for follicular rupture during ovulation in mice
  25. Targeting copper metabolism to defeat KRAS-driven colorectal cancer
  26. STRIPAK regulates Slik localization to control mitotic morphogenesis and epithelial integrity
  27. An ErbB2 splice variant lacking exon 16 drives lung carcinoma
  28. Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
  29. SPIN90 associates with mDia1 and the Arp2/3 complex to regulate cortical actin organization
  30. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling
  31. NF45 and NF90 Regulate Mitotic Gene Expression by Competing with Staufen-Mediated mRNA Decay
  32. Controversies around the function of LARP1
  33. Publisher Correction: Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1
  34. F-Actin Interactome Reveals Vimentin as a Key Regulator of Actin Organization and Cell Mechanics in Mitosis
  35. Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion
  36. Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1
  37. Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities
  38. Misshapen coordinates protrusion restriction and actomyosin contractility during collective cell migration
  39. Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
  40. Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children
  41. ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation
  42. Nckipsd Coordinates Arp2/3 and Formin Nucleation of Actin Filaments in the Cell Cortex
  43. Genetic Landscape of Electron Transport Chain Complex I Dependency in Acute Myeloid Leukemia
  44. Coordination of Pro- and Anti-Inflammatory Signals Determine Human Hematopoietic Stem and Progenitor Cell Expansion
  45. Germline GAB2 Mutations in Childhood Acute Lymphoblastic Leukemia
  46. Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of Mitochondrial Vulnerability in Acute Myeloid Leukemia
  47. Abstract 3502: Chemoproteomics provide insights into cell surface reprogramming during KRAS-mediated transformation
  48. The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
  49. RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma
  50. Signaling Pathways Involved in the Regulation of mRNA Translation
  51. Defining the role of the RSK isoforms in cancer
  52. CdGAP/ARHGAP31 is regulated by RSK phosphorylation and binding to 14-3-3β adaptor protein
  53. RSK (p90 Ribosomal S6 Kinase)
  54. Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition
  55. EPCR expression marks UM171-expanded CD34+ cord blood stem cells
  56. Actin cortex architecture regulates cell surface tension
  57. A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling
  58. Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 To Promote a Negative-Feedback Loop That Attenuates Phosphoinositide 3-Kinase/Akt Signaling
  59. Targeting Pre-Leukemic Stem Cells in T-Acute Lymphoblastic Leukemia
  60. Proteomics Screen Identifies Class I Rab11 Family Interacting Proteins as Key Regulators of Cytokinesis
  61. High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells
  62. RSK (p90 Ribosomal S6 Kinase)
  63. ISDN2014_0400: Mutations in DOCK7 in individuals with epileptic encephalopathy and cortical blindness
  64. Targeting pre-leukemic stem cells in T-acute lymphoblastic leukemia
  65. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression
  66. Translational control by oncogenic signaling pathways
  67. Effect of the Transient Pharmacological Inhibition of Mapk3/1 Pathway on Ovulation in Mice
  68. The expanding role of mTOR in cancer cell growth and proliferation
  69. Regulation of global and specific mRNA translation by the mTOR signaling pathway
  70. A biosensor to monitor dynamic regulation and function of tumour suppressor PTEN in living cells
  71. Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3
  72. Cellular Control of Cortical Actin Nucleation
  73. Mechanistic target of rapamycin (MTOR) signaling during ovulation in mice
  74. Mutations in DOCK7 in Individuals with Epileptic Encephalopathy and Cortical Blindness
  75. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
  76. Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5′TOP mRNA translation
  77. Casein Kinase 1ϵ Promotes Cell Proliferation by Regulating mRNA Translation
  78. The Coming of Age of Phosphoproteomics—from Large Data Sets to Inference of Protein Functions
  79. Cell cortex composition and homeostasis resolved by integrating proteomics and quantitative imaging
  80. Rapamycin Resistance: mTORC1 Substrates Hold Some of the Answers
  81. Insulin Activates RSK (p90 Ribosomal S6 Kinase) to Trigger a New Negative Feedback Loop That Regulates Insulin Signaling for Glucose Metabolism
  82. Cell cycle regulation of Greatwall kinase nuclear localization facilitates mitotic progression
  83. Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly
  84. Abstract 5191: Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility.
  85. Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1
  86. Gab2 Phosphorylation by RSK Inhibits Shp2 Recruitment and Cell Motility
  87. RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance
  88. RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation
  89. Phosphorylation of the Eukaryotic Translation Initiation Factor 4E-Transporter (4E-T) by c-Jun N-Terminal Kinase Promotes Stress-Dependent P-Body Assembly
  90. Regulation of mRNA Translation by Signaling Pathways
  91. RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth
  92. F-Box Proteins Elongate Translation During Stress Recovery
  93. Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
  94. Regulation of Karyopherin α1 and Nuclear Import by Mammalian Target of Rapamycin
  95. Regulation and function of the RSK family of protein kinases
  96. RSK (p90 Ribosomal S6 Kinase)
  97. Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
  98. A comprehensive map of the mTOR signaling network
  99. mTOR, la cible fonctionnelle de la rapamycine
  100. ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)
  101. mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide
  102. Paving the way for targeting RSK in cancer
  103. Transmembrane Receptor DCC Associates with Protein Synthesis Machinery and Regulates Translation
  104. mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling
  105. Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser 863 and Multisite Phosphorylation
  106. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
  107. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
  108. Oncogenic MAPK Signaling Stimulates mTORC1 Activity by Promoting RSK-Mediated Raptor Phosphorylation
  109. The RSK factors of activating the Ras/MAPK signaling cascade
  110. Rsk4
  111. Rsk3
  112. Rsk1
  113. RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation
  114. Mind the GAP: Wnt Steps onto the mTORC1 Train
  115. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
  116. The Tumor Suppressor DAP Kinase Is a Target of RSK-Mediated Survival Signaling
  117. Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors
  118. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase
  119. ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions
  120. Protein Kinase A Activation Promotes Plasma Membrane Insertion of DCC from an Intracellular Pool: A Novel Mechanism Regulating Commissural Axon Extension
  121. Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb
  122. Phosphorylation of p90 Ribosomal S6 Kinase (RSK) Regulates Extracellular Signal-Regulated Kinase Docking and RSK Activity
  123. K252a and CEP1347 Are Neuroprotective Compounds That Inhibit Mixed-lineage Kinase-3 and Induce Activation of Akt and ERK
  124. Neurotrophin signaling through the p75 neurotrophin receptor
  125. The p75 Neurotrophin Receptor Activates Akt (Protein Kinase B) through a Phosphatidylinositol 3-Kinase-dependent Pathway
  126. NRAGE, A Novel MAGE Protein, Interacts with the p75 Neurotrophin Receptor and Facilitates Nerve Growth Factor–Dependent Apoptosis
  127. Activation of Transcription Factors NF-κB and NF-IL-6 by Human Immunodeficiency Virus Type 1 Protein R (Vpr) Induces Interleukin-8 Expression
  128. p75 Neurotrophin Receptor Expression Is Induced in Apoptotic Neurons After Seizure
  129. The p75 Neurotrophin Receptor (p75NTR) Alters Tumor Necrosis Factor-mediated NF- B Activity under Physiological Conditions, but Direct p75NTR-mediated NF- B Activation Requires Cell Stress
  130. INCREASED APOPTOSIS, CHANGES IN INTRACELLULAR Ca2+, AND FUNCTIONAL ALTERATIONS IN LYMPHOCYTES AND MACROPHAGES AFTER IN VITRO EXPOSURE TO STATIC MAGNETIC FIELD
  131. MAPK Signaling in Human Diseases